Summit Therapeutics Inc. (SMMT) /
The debt of Summit Therapeutics Inc. over the past 8 years
Chart Summit Therapeutics Inc.: liquid cash, total debt, net cash, fiscal 2018–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, Summit Therapeutics Inc. had liquid cash of $713.45M and total debt of $0: net cash of $713.45M. It had more liquid cash than debt at 5 of the 6 year-ends shown. Total debt was highest at the end of fiscal 2022 ($514.31M) and lowest at the end of fiscal 2019 ($0). No net cash figure is on file for fiscal 2024.
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $713.45M* | $0 | $713.45M |
| 2024ended Dec 31, 2024 | $412.35M* | — | — |
| 2023ended Dec 31, 2023 | $186.24M* | $100M | $86.24M |
| 2022ended Dec 31, 2022 | $348.61M* | $514.31M | -$165.7M |
| 2021ended Dec 31, 2021 | $71.79M | $0 | $71.79M |
| 2020ended Dec 31, 2020 | $66.42M | $0 | $66.42M |
| 2019ended Jan 31, 2019 | $35.24M | $0 | $35.24M |
| 2018ended Jan 31, 2018 | — | — | — |
Fiscal years as Summit Therapeutics Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Summit Therapeutics Inc.
- The revenue of Summit Therapeutics Inc.
- The profitability of Summit Therapeutics Inc.
- The cash flow of Summit Therapeutics Inc.
- All of Summit Therapeutics Inc.'s financials, charted
Companies of a similar size
- DVADAVITA INC.
- WTSWATTS WATER TECHNOLOGIES INC
- FDSFACTSET RESEARCH SYSTEMS INC.
- AITAPPLIED INDUSTRIAL TECHNOLOGIES, INC.
- ALLYAlly Financial Inc.
Not investment advice. This page shows what Summit Therapeutics Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.